RACGP backs vision for national hepatitis strategies The college has put forward recommendations to strengthen the draft 2023–30 strategies and ensure targets are met.
Study linking HRT with dementia risk ‘unhelpful’ Experts point out that no causal relationship between menopausal hormone therapy and dementia has been established.
Does multimorbidity impact chronic disease treatment? New international research has looked into a range of chronic diseases and their potential impact on effectiveness of common medications.
‘Historic’ funding changes for opioid dependency treatment Addiction GPs say the changes will help to reduce barriers when it comes to prescribing and access – and in the process reduce stigma.
Opioid treatment receives $377m funding increase The measure, included in this week’s Federal Budget, will ‘save lives’, according to the RACGP President.
Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
Can doctor–patient differences have clinical implications? New research suggests doctors are more extroverted, but also more neurotic and less open than patients.
Program aims to ‘scale up’ hepatitis C testing GPs are being encouraged to sign up for Beyond the C, which is hoping to move Australia closer to eliminating the virus by 2030.
Review seeks to solve Better Access flaws Disparities in mental health access is a major theme of a comprehensive Government-commissioned evaluation of the 16-year-old initiative.
Upcoming MBS changes GPs need to know From 1 November, a number of MBS changes will be instituted that are likely to have some impact on general practice.